NasdaqCM - Delayed Quote USD
Revelation Biosciences, Inc. (REVBW)
0.0102
-0.0034
(-25.00%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
7,975.1090
7,975.1090
8,656.6640
10,864.5110
11,950.4850
Operating Income
-7,975.1090
-7,975.1090
-8,656.6640
-10,864.5110
-11,950.4850
Other Income Expense
-7,063.4270
-7,063.4270
8,536.4100
34.9620
-36.3520
Pretax Income
-15,038.5360
-15,038.5360
-120.2540
-10,829.5490
-11,986.8370
Net Income Common Stockholders
-15,038.5360
-15,038.5360
-120.2540
-10,829.5490
-11,986.8370
Diluted NI Available to Com Stockholders
-15,038.5360
-15,038.5360
-120.2540
-10,829.5490
-11,986.8370
Total Operating Income as Reported
-7,975.1090
-7,975.1090
-8,656.6640
-10,864.5110
-11,950.4850
Total Expenses
7,975.1090
7,975.1090
8,656.6640
10,864.5110
11,950.4850
Net Income from Continuing & Discontinued Operation
-15,038.5360
-15,038.5360
-120.2540
-10,829.5490
-11,986.8370
Normalized Income
-15,119.9770
-15,119.9770
-8,449.1910
-10,829.5490
-11,986.8370
EBIT
-7,975.1090
-7,975.1090
-8,656.6640
-10,864.5110
-11,950.4850
EBITDA
-7,947.1860
-7,947.1860
-8,631.6150
-10,839.4630
-11,933.7030
Reconciled Depreciation
27.9230
27.9230
25.0490
25.0480
16.7820
Net Income from Continuing Operation Net Minority Interest
-15,038.5360
-15,038.5360
-120.2540
-10,829.5490
-11,986.8370
Total Unusual Items Excluding Goodwill
81.4410
81.4410
8,328.9370
--
--
Total Unusual Items
81.4410
81.4410
8,328.9370
--
--
Normalized EBITDA
-8,028.6270
-8,028.6270
-16,960.5520
-10,839.4630
-11,933.7030
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIXTW Lixte Biotechnology Holdings, Inc.
0.0297
+40.76%
APLMW Apollomics, Inc.
0.0101
-32.67%
NRSNW NeuroSense Therapeutics Ltd.
0.2560
-3.76%
NRXPW NRx Pharmaceuticals, Inc.
0.0610
-11.08%
EFTR eFFECTOR Therapeutics, Inc.
0.0002
0.00%
HUMAW Humacyte, Inc.
0.3101
-8.79%
MTVA MetaVia Inc.
0.7789
+2.22%
NRSN NeuroSense Therapeutics Ltd.
1.0300
+0.98%
ZNTL Zentalis Pharmaceuticals, Inc.
1.4500
0.00%
KPRX Kiora Pharmaceuticals, Inc.
3.3150
+0.76%